My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 399

    1.

    C-reactive protein levels are not associated with increased risk for colorectal cancer in women.

    Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM.

    Ann Intern Med. 2005 Mar 15;142(6):425-32.PMID: 15767620 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    C-reactive protein and the risk of incident colorectal cancer.

    Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ.

    JAMA. 2004 Feb 4;291(5):585-90.PMID: 14762037 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.

    Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM.

    JAMA. 2002 Aug 28;288(8):980-7.PMID: 12190368 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men.

    Pirro M, Bergeron J, Dagenais GR, Bernard PM, Cantin B, Després JP, Lamarche B.

    Arch Intern Med. 2001 Nov 12;161(20):2474-80.PMID: 11700160 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

    Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM.

    JAMA. 2001 Jul 18;286(3):327-34.PMID: 11466099 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.

    Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG, Hofman A, Pols HA, Stricker BH.

    J Clin Oncol. 2006 Nov 20;24(33):5216-22.PMID: 17114654 [PubMed - indexed for MEDLINE]Related articles

    7.

    Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group.

    Nielsen HJ, Christensen IJ, Sørensen S, Moesgaard F, Brünner N.

    Ann Surg Oncol. 2000 Sep;7(8):617-23.PMID: 11005561 [PubMed - indexed for MEDLINE]Related articles

    8.

    Colorectal cancer and serum C-reactive protein levels: a case-control study nested in the JACC Study.

    Ito Y, Suzuki K, Tamakoshi K, Wakai K, Kojima M, Ozasa K, Watanabe Y, Kawado M, Hashimoto S, Suzuki S, Tokudome S, Toyoshima H, Hayakawa N, Kato K, Watanabe M, Ohta Y, Maruta M, Tamakoshi A; JACC Study Group.

    J Epidemiol. 2005 Jun;15 Suppl 2:S185-9.PMID: 16127232 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Summaries for patients. Can a blood test help predict who is at risk for colorectal cancer?

    [No authors listed]

    Ann Intern Med. 2005 Mar 15;142(6):I79. No abstract available. PMID: 15767616 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Is C-reactive protein specific for vascular disease in women?

    Rifai N, Buring JE, Lee IM, Manson JE, Ridker PM.

    Ann Intern Med. 2002 Apr 2;136(7):529-33.PMID: 11926788 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.

    Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE.

    JAMA. 2005 Jul 20;294(3):326-33.PMID: 16030277 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A prospective study of serum C-reactive protein and colorectal cancer risk in men.

    Gunter MJ, Stolzenberg-Solomon R, Cross AJ, Leitzmann MF, Weinstein S, Wood RJ, Virtamo J, Taylor PR, Albanes D, Sinha R.

    Cancer Res. 2006 Feb 15;66(4):2483-7.PMID: 16489056 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    C-reactive protein and risk of breast cancer.

    Zhang SM, Lin J, Cook NR, Lee IM, Manson JE, Buring JE, Ridker PM.

    J Natl Cancer Inst. 2007 Jun 6;99(11):890-4.PMID: 17551149 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    C-reactive protein and the risk of developing hypertension.

    Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM.

    JAMA. 2003 Dec 10;290(22):2945-51.PMID: 14665655 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.

    Musicant SE, Taylor LM Jr, Peters D, Schuff RA, Urankar R, Landry GJ, Moneta GL.

    J Vasc Surg. 2006 Apr;43(4):772-80; discussion 780.PMID: 16616235 [PubMed - indexed for MEDLINE]Related articles

    16.

    Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.

    Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S; Japan Public Health Center-Based Prospective Study Group.

    Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):690-5.PMID: 16614110 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    High levels of plasma C-reactive protein and future risk of age-related cataract.

    Schaumberg DA, Ridker PM, Glynn RJ, Christen WG, Dana MR, Hennekens CH.

    Ann Epidemiol. 1999 Apr;9(3):166-71.PMID: 10192648 [PubMed - indexed for MEDLINE]Related articles

    18.

    Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.

    Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS.

    JAMA. 2005 Aug 24;294(8):914-23.PMID: 16118381 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men.

    Chiu HM, Lin JT, Chen TH, Lee YC, Chiu YH, Liang JT, Shun CT, Wu MS.

    Am J Gastroenterol. 2008 Sep;103(9):2317-25.PMID: 18844617 [PubMed - indexed for MEDLINE]Related articles

    20.

    Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.

    Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Chambless LE, Myerson M, Wu KK, Sharrett AR, Boerwinkle E.

    Arch Intern Med. 2005 Nov 28;165(21):2479-84.PMID: 16314544 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity